These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24829925)

  • 1. Ketosis onset type 2 diabetes had better islet β-cell function and more serious insulin resistance.
    Lu H; Hu F; Zeng Y; Zou L; Luo S; Sun Y; Liu H; Sun L
    J Diabetes Res; 2014; 2014():510643. PubMed ID: 24829925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The classification and prognostic implication of islet β cell function before and in remission period in newly diagnosed diabetic patients with ketosis].
    Fan H; Zhang PR; Liu J; Xu Y
    Zhonghua Nei Ke Za Zhi; 2012 Feb; 51(2):108-13. PubMed ID: 22490810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of idiopathic type 1 diabetes with subsequent recovery of endogenous insulin secretion despite initial diagnosis of fulminant type 1 diabetes.
    Kaneko K; Satake C; Yamamoto J; Takahashi H; Sawada S; Imai J; Yamada T; Katagiri H
    Endocr J; 2017 Mar; 64(3):369-374. PubMed ID: 28070056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Insulin resistance and islet beta cell function in type 2 diabetes mellitus and non alcoholic fatty liver disease.].
    Li FP; Zhang SQ; Wang F; Huang YQ; Fu ZZ; Yan L
    Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):940-3. PubMed ID: 20079327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential patterns of insulin secretion and sensitivity in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease versus patients with type 2 diabetes mellitus alone.
    Chai SY; Pan XY; Song KX; Huang YY; Li F; Cheng XY; Qu S
    Lipids Health Dis; 2014 Jan; 13():7. PubMed ID: 24397589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketosis-prone atypical diabetes in Cameroonian people with hyperglycaemic crisis: frequency, clinical and metabolic phenotypes.
    Lontchi-Yimagou E; Nguewa JL; Assah F; Noubiap JJ; Boudou P; Djahmeni E; Balti EV; Atogho-Tiedeu B; Gautier JF; Mbanya JC; Sobngwi E
    Diabet Med; 2017 Mar; 34(3):426-431. PubMed ID: 27657549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical value of glycosylated hemoglobin level in newly diagnosed ketosis-prone type 2 diabetes.
    Min R; Xu Y; Peng B
    Front Endocrinol (Lausanne); 2023; 14():1244008. PubMed ID: 38027130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired β cell function in Chinese newly diagnosed type 2 diabetes mellitus with hyperlipidemia.
    Ma Y; Wang Y; Huang Q; Ren Q; Chen S; Zhang A; Zhao L; Zhen Q; Peng Y
    J Diabetes Res; 2014; 2014():493039. PubMed ID: 24829924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pantoprazole may improve beta cell function and diabetes mellitus.
    Inci F; Atmaca M; Ozturk M; Yildiz S; Koceroglu R; Sekeroglu R; Ipekci SH; Kebapcilar L
    J Endocrinol Invest; 2014 May; 37(5):449-54. PubMed ID: 24682913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved glycemic control enhances the incretin effect in patients with type 2 diabetes.
    An Z; Prigeon RL; D'Alessio DA
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4702-8. PubMed ID: 24092826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of short-term prednisone on beta-cell function in subjects with type 2 diabetes mellitus and healthy subjects.
    Shah M; Adel MM; Tahsin B; Guerra Y; Fogelfeld L
    PLoS One; 2020; 15(5):e0231190. PubMed ID: 32369480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of lipotoxicity effect on {beta}-cell dysfunction in ketosis-prone type 2 diabetes.
    Umpierrez GE; Smiley D; Robalino G; Peng L; Gosmanov AR; Kitabchi AE
    Diabetes Care; 2010 Mar; 33(3):626-31. PubMed ID: 20028938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous clinical features of ketosis-prone type 2 diabetes mellitus patients: gender, age, loss of weight and HbA1c.
    Wang J; Zhang M; Liu Z; Wang X; Pang Y; Lu Y; Liu Z
    Minerva Endocrinol; 2019 Dec; 44(4):351-356. PubMed ID: 30482009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between circadian blood pressure variability and function of islet α and β cell in type 2 diabetes with dyssomnia.
    Ren HZ; Zheng MY; Shan CY; Yang JH; Xu YG; Yang YH; Wang Y; Chen LM; Chang BC
    J Diabetes Complications; 2015 Jul; 29(5):675-8. PubMed ID: 25957006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of metformin and repaglinide monotherapy in the treatment of new onset type 2 diabetes mellitus in China.
    Ma J; Liu LY; Wu PH; Liao Y; Tao T; Liu W
    J Diabetes Res; 2014; 2014():294017. PubMed ID: 24772445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 diabetes mellitus in African-American adolescents: impaired beta-cell function in the face of severe insulin resistance.
    Taha D; Umpaichitra V; Banerji MA; Castells S
    J Pediatr Endocrinol Metab; 2006 Feb; 19(2):135-42. PubMed ID: 16562586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical characteristics and classification diagnosis of newly diagnosed diabetes onset with ketosis or ketoacidosis in adult patients].
    Liu HX; Li GM; Zhou YW; Luo SH; Zheng XY; Yang DZ; Liang H; Yan JH; Yao B; Weng JP
    Zhonghua Yi Xue Za Zhi; 2019 May; 99(18):1369-1374. PubMed ID: 31137122
    [No Abstract]   [Full Text] [Related]  

  • 18. Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)) without hyperinsulinemia in patients with type 2 diabetes mellitus.
    Bermúdez-Pirela VJ; Cano C; Medina MT; Souki A; Lemus MA; Leal EM; Seyfi HA; Cano R; Ciscek A; Bermúdez-Arias F; Contreras F; Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):194-202. PubMed ID: 17414590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
    Guo M; Xi G; Yang N; Yao H
    Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of and risk factors for diabetic ketosis in Chinese diabetic patients with random blood glucose levels >13.9 mmol/L: Results from the CHina study in prEvalence of diabetiC Ketosis (CHECK) study.
    Gao L; Li Y; Fei D; Ma L; Chen S; Feng B; Su Q; Ji L
    J Diabetes; 2018 Mar; 10(3):249-255. PubMed ID: 28685968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.